Showing results (261-270 of 284) with videos related to
Sort By:
Pageof 29
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaR S Freedman, J A Gibbons, M Giedlin, et al.Cancer Research|October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroG Ferrandina, B Melichar, A Loercher, et al.Sleep|June 1, 1989
Sleep-disordered breathing in healthy aged persons: one-year follow-up of daytime sequelaeD T Berry, B A Phillips, Y R Cook, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.American Journal of Clinical Oncology|February 22, 2000
Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference]S Verstovsek, C F Verschraegen, C L Edwards, et al.European Journal of Gynaecological Oncology|January 1, 1997
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literatureS Piamsomboon, A P Kudelka, W Termrungruanglert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.Anti-Cancer Drugs|June 1, 1996
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, C F Verschraegen, T Levy, et al.Annals of Internal Medicine|February 26, 2000
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancerS Vadhan-Raj, C F Verschraegen, C Bueso-Ramos, et al.Gynecologic Oncology|August 25, 2001
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancerM L Donato, D M Gershenson, J T Wharton, et al.Pageof 29